We are live on ! Find out more
GHCM

Glen Harbor Capital Management Portfolio holdings

AUM $4.82B
1-Year Est. Return 4.69%
This Fund
S&P 500
This Quarter Est. Return
-13.09%
1 Year Est. Return
+4.69%
3 Year Est. Return
+49.45%
5 Year Est. Return
10 Year Est. Return
AUM
$4.14B
AUM Growth
-$839M
Cap. Flow
-$133M
Cap. Flow %
-3.21%
Top 10 Hldgs %
20.73%
Holding
1,388
New
110
Increased
453
Reduced
349
Closed
107

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$27.7M
2
LIN icon
Linde
LIN
+$26.4M
3
CI icon
Cigna
CI
+$25.2M
4
XOM icon
ExxonMobil
XOM
+$23.3M
5
UNP icon
Union Pacific
UNP
+$10.2M

Sector Composition

Rank Sector Weight
1 Technology 17%
2 Financials 15.58%
3 Healthcare 14.58%
4 Consumer Discretionary 11.24%
5 Industrials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEWR
1251
DELISTED
New Relic, Inc.
NEWR
$16K ﹤0.01%
+196
New +$16.5K
DNTH icon
1252
Dianthus Therapeutics
DNTH
$5.86B
$15K ﹤0.01%
162
-131
-45% -$17.9K
SNDX icon
1253
Syndax Pharmaceuticals
SNDX
$1.62B
$15K ﹤0.01%
+3,366
New +$18.5K
PRTK
1254
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$15K ﹤0.01%
+2,912
New +$22.1K
COUP
1255
DELISTED
Coupa Software Incorporated
COUP
$15K ﹤0.01%
+242
New +$15.3K
NUAN
1256
DELISTED
Nuance Communications, Inc.
NUAN
$15K ﹤0.01%
+1,271
New +$17.8K
VRNT
1257
DELISTED
Verint Systems
VRNT
$14K ﹤0.01%
+648
New +$14.9K
ARNA
1258
DELISTED
Arena Pharmaceuticals Inc
ARNA
$13K ﹤0.01%
+336
New +$13.2K
RNG icon
1259
RingCentral
RNG
$6.05B
$12K ﹤0.01%
+144
New +$11.3K
ALTR
1260
DELISTED
Altair Engineering Inc
ALTR
$12K ﹤0.01%
+418
New +$13.8K
FATE icon
1261
Fate Therapeutics
FATE
$282M
$11K ﹤0.01%
+896
New +$12.5K
SSTI icon
1262
SoundThinking
SSTI
$77.9M
$11K ﹤0.01%
+352
New +$13.1K
SNNA
1263
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$11K ﹤0.01%
4,752
-13,882
-74% -$122K
DBX icon
1264
Dropbox
DBX
$8.18B
$10K ﹤0.01%
+512
New +$11.8K
XLI icon
1265
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
$10K ﹤0.01%
160
-224
-58% -$15.9K
CSOD
1266
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$10K ﹤0.01%
+192
New +$9.73K
MDGL icon
1267
Madrigal Pharmaceuticals
MDGL
$12.1B
$8K ﹤0.01%
+68
New +$10.5K
UPLD icon
1268
Upland Software
UPLD
$11.1M
$8K ﹤0.01%
+29
New +$8.7K
IOVA icon
1269
Iovance Biotherapeutics
IOVA
$4.24B
$7K ﹤0.01%
+832
New +$8.02K
REPL icon
1270
Replimune Group
REPL
$1.23B
$7K ﹤0.01%
656
-1,072
-62% -$14.5K
VCIT icon
1271
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$68.7B
$7K ﹤0.01%
88
SCG
1272
DELISTED
Scana
SCG
$6K ﹤0.01%
136
-952
-88% -$40.9K
TARA icon
1273
Protara Therapeutics
TARA
$222M
$5K ﹤0.01%
+60
New +$4.24K
ARRY
1274
DELISTED
Array Biopharma Inc
ARRY
$5K ﹤0.01%
+336
New +$5.1K
SRRK icon
1275
Scholar Rock
SRRK
$6.09B
$4K ﹤0.01%
+170
New +$3.84K

Similar funds

Glen Harbor Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Glen Harbor Capital Management held 1,388 positions worth $4.14B, down 17% from $4.98B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Glen Harbor Capital Management withdrew a net $133M in Q4 2018, closing 107 positions and reducing 349 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $79.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Glen Harbor Capital Management opened a new position in Linde worth $26.1M.

  • Glen Harbor Capital Management's largest Q4 2018 buy was Linde: 167,076 shares worth $26.1M.
  • Glen Harbor Capital Management added most to ConocoPhillips in Q4 2018, an estimated $27.7M increase.
  • Glen Harbor Capital Management's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $25.3M.
  • Glen Harbor Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $79.1M.
  • Glen Harbor Capital Management's ten largest holdings make up 21% of its $4.14B portfolio in Q4 2018.
  • Glen Harbor Capital Management opened 110 new positions and closed 107 in Q4 2018.
  • Glen Harbor Capital Management's portfolio value fell 17% quarter-over-quarter to $4.14B.

Based on Glen Harbor Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.